OC 000459 in patients with eosinophilc oesophagitis

Trial Profile

OC 000459 in patients with eosinophilc oesophagitis

Phase of Trial: Phase II

Latest Information Update: 16 Oct 2013

At a glance

  • Drugs Timapiprant (Primary)
  • Indications Eosinophilic oesophagitis
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 16 Oct 2013 Results presented at the 21st United European Gastroenterology Week.
    • 26 May 2012 New trial record
    • 22 May 2012 Results presented at Digestive Disease Week 2012.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top